论文部分内容阅读
结核病现阶段依然为我国传染病防控领域的重中之重,究其原因首先为我国结核病人基数较大,位居世界第2位,其次为近年来耐药性结核病人呈现大幅度增长,疫情形势严峻。相较药物敏感性结核患者,耐药性结核病人无论从传染病防控到医疗救治,均给社会造成了极大的隐患和负担,因此我国耐药结核病疫情形势也被世界卫生组织高度关注。按照WHO 2014年公布的结果,全球现有耐多药结核(MDR-TB)患者预计达50余万,而按照“2010年
At present, tuberculosis remains the top priority in the field of prevention and control of infectious diseases in our country. The reason for this is firstly that the base number of tuberculosis patients in our country is relatively large, ranking the second in the world, followed by the substantial increase in drug-resistant tuberculosis patients in recent years, The situation is grim. Compared with drug-sensitive TB patients, drug-resistant TB patients have caused great hidden dangers and burdens on the community, not only from the prevention and control of infectious diseases but also from medical treatment. Therefore, the epidemic situation of drug-resistant TB in our country has also been highly concerned by the World Health Organization. According to the results announced by the WHO in 2014, the number of existing MDR-TB patients in the world is estimated to reach over 500,000. According to the 2010 ”